Endorphins: Physiology and What Research Reports

What Endorphins Are

Endorphins are endogenous opioid peptides — signalling molecules made inside the body that act at the same receptor family targeted by opioid drugs. A biochemistry review of endorphins described them as peptides cleaved from the larger precursor protein proopiomelanocortin (POMC), with beta-endorphin as the best-characterised member, acting at opioid receptors to modulate pain transmission and mood-related signalling (PMID 29262177). Because they are short chains of amino acids, endorphins are frequently encountered in peptide literature, and the phrase “endorphin peptide” simply reflects that chemical class rather than a specific product.

Endorphins are not a single molecule. The term covers several POMC-derived fragments, and the same biochemistry review grouped them with other endogenous opioid families that share affinity for mu, delta and kappa opioid receptors (PMID 29262177).

Where Endorphins Are Produced

The classical sources are the pituitary gland and the hypothalamus, where POMC processing yields beta-endorphin alongside other peptide fragments, as outlined in the biochemistry review of endorphin synthesis and receptor binding (PMID 29262177). Endorphin production is not limited to the brain and pituitary, however. Researchers measured beta-endorphin within leukocytes of people living with HIV and chronic widespread pain, and the study reported that heme exposure attenuated leukocyte beta-endorphin levels (PMID 32828015). Reproductive tissue has also been studied: an in vitro experiment applied beta-endorphin to bovine endometrial cells and reported that it inhibited the inflammatory response through the delta opioid receptor (PMID 33775662).

Physiological Roles Described in the Literature

Pain and nociception

The most established framing is analgesic. The biochemistry review described endorphins as endogenous opioid ligands that dampen pain signalling via opioid receptor activation (PMID 29262177). Clinical pain research has used beta-endorphin as a candidate biomarker rather than a treatment: in a cohort of HIV-positive individuals with chronic widespread pain, researchers reported that leukocyte beta-endorphin levels were attenuated by heme (PMID 32828015).

Reproduction, sexuality and labour

A 2024 review in Advances in Neurobiology examined endorphins in the context of sexuality and reproduction, summarising how endogenous opioid signalling intersects with reproductive physiology and sexual behaviour (PMID 38874734). In midwifery, a practice-focused article discussed “optimising endorphins” around labour and birth, framing endogenous opioid release as part of the physiology of labour rather than as an administered agent (PMID 23243831).

Immune and inflammatory signalling

Endorphins interact with immune cells, which is why several papers treated them as neuro-immune messengers. The bovine endometrial cell experiment reported an anti-inflammatory effect of beta-endorphin mediated by the delta opioid receptor in vitro (PMID 33775662). That finding came from cultured cells, so it describes a mechanism observed in a dish, not an outcome in an intact organism.

Exercise physiology and the gut

Exercise is the context in which the word “endorphins” is most often used casually, but exercise studies have also produced negative findings. A preliminary study in professional cyclists concluded that beta-endorphins were not responsible for the delayed gastric emptying of digestible solids observed after exercise (PMID 35964812). The authors described the work as preliminary, which limits how far the conclusion can be generalised.

Endorphins in Disease-Focused Research

Beyond pain and reproduction, endorphins appear in psychiatric and oncology literature as measured analytes or as review topics.

Reviews of this kind gather mechanistic and observational material; they do not establish that changing endorphin levels alters disease course. The breast cancer review was published as a book chapter surveying pathogenesis and recovery themes (PMID 38874719), and the oncology commentary presented beta-endorphins within a broader holistic model (PMID 32669986).

How Endorphins Are Measured and Studied

Four broad approaches recur in the papers summarised here:

• Circulating peptide assays. Blood beta-endorphin measured before and after an intervention, as in the schizophrenia comparison of beta-endorphin and CGRP levels (PMID 27143887).
• Cell-associated measurement. Beta-endorphin quantified inside leukocytes rather than in plasma (PMID 32828015).
• In vitro receptor pharmacology. Cultured cells exposed to beta-endorphin with receptor-specific readouts, as in the delta opioid receptor experiment in bovine endometrial cells (PMID 33775662).
• Physiological challenge studies. Exercise protocols with a functional endpoint, such as gastric emptying in professional cyclists (PMID 35964812).

An important interpretive caution runs through all of them: peripheral beta-endorphin concentrations are an indirect window onto central opioid activity, and a change in a measured level does not by itself demonstrate a change in how a person feels or functions.

Why the Term Matters in Peptide Research

Endorphins are a reference point for anyone reading peptide literature. They illustrate how a single precursor protein can be processed into multiple bioactive peptides (PMID 29262177), how one peptide can act on more than one receptor subtype (PMID 33775662), and how the same molecule can be studied as a biomarker in psychiatry (PMID 27143887) and as a review topic in oncology (PMID 38874719). Readers who meet “endorphins” in marketing copy are usually meeting a physiological concept, not a characterised product.

Endorphins: What Studies Report on Tolerability and Negative Findings

None of the papers summarised on this page reported an adverse-event profile for administering endorphin peptides to humans, and none described dosing schedules; the human work measured endogenous levels or reviewed existing findings. The clearest negative result came from exercise physiology, where the study in professional cyclists reported that beta-endorphins were not responsible for delayed gastric emptying of digestible solids after exercise (PMID 35964812). Because endorphins act at opioid receptors, the biochemistry review situated them within the same receptor system as opioid pharmacology (PMID 29262177), but that shared target does not translate into safety or tolerability data that these papers did not collect.

Limitations

1. Several sources are narrative reviews or book chapters (PMID 38874734, PMID 38874719) rather than controlled trials.
2. One mechanistic result came from animal-derived cells in culture (PMID 33775662).
3. At least one clinical report described itself as preliminary (PMID 35964812).
4. Practice-oriented articles such as the midwifery discussion of optimising endorphins in labour addressed care context rather than peptide pharmacology (PMID 23243831).

This page is for educational purposes only and is not medical advice; consult a licensed physician for questions about health, symptoms, medications or any substance discussed in the research summarised here.

References

• Biochemistry, Endorphin (StatPearls, 2026)
• Endorphins, Sexuality, and Reproduction (Advances in Neurobiology, 2024)
• Role of Endorphins in Breast Cancer Pathogenesis and Recovery (Advances in Neurobiology, 2024)
• Optimising endorphins (The Practising Midwife, 2012)
• Comparison of beta-endorphin and CGRP levels before and after treatment for severe schizophrenia (Neuropsychiatric Disease and Treatment, 2016)
• Beta endorphins - holistic therapeutic approach to cancer (Annals of Ibadan Postgraduate Medicine, 2019)
• β-Endorphins are not responsible for delayed gastric emptying of digestible solids after exercise in professional cyclists. A preliminary study (Gastroenterología y Hepatología, 2023)
• Beta-endorphin inhibits the inflammatory response of bovine endometrial cells through δ opioid receptor in vitro (Developmental and Comparative Immunology, 2021)
• Heme attenuates beta-endorphin levels in leukocytes of HIV positive individuals with chronic widespread pain (Redox Biology, 2020)